inducible T cell kinase". University of California
San Diego, Ph.D. dissertation, pp. 91, 205
(2012).
9. Stemke, Anastasia, "Immunotherapy with tumor
antigen-specific T cells in ret transgenic mouse
MDM4 M NP_001191100.1 y n/d n/d
450 MeCP2 M9317 4204 MECP2 P NP_001104262.1,NP_004983.1 y n/d n/d
451 MeCP2 M7443 4204 MECP2 M NP_001104262.1,NP_004983.1 y y y
452 MeCP2 M6818 4204 MECP2 M NP_001104262.1
MDM4 M NP_001191100.1 y n/d n/d
450 MeCP2 M9317 4204 MECP2 P NP_001104262.1,NP_004983.1 y n/d n/d
451 MeCP2 M7443 4204 MECP2 M NP_001104262.1,NP_004983.1 y y y
452 MeCP2 M6818 4204 MECP2 M NP_001104262.1
MDM4 M NP_001191100.1 y n/d n/d
450 MeCP2 M9317 4204 MECP2 P NP_001104262.1,NP_004983.1 y n/d n/d
451 MeCP2 M7443 4204 MECP2 M NP_001104262.1,NP_004983.1 y y y
452 MeCP2 M6818 4204 MECP2 M NP_001104262.1
MDM2 M4308 M y y y
448 MDM2 M7815 M y y n/d
449 MDMX M0445 M y n/d n/d
450 MeCP2 M9317 P y n/d n/d
451 MeCP2 M7443 M y y y
452 MeCP2 M6818 M y y y
453 MEKK4 M7194 M
n/d
450 MeCP2 M9317 4204, 29386, 17257 Mecp2,MECP2 NP_004983.1,NP_073164.2,NP_034918.1 P y n/d n/d
451 MeCP2 M7443 4204, 29386, 17257 Mecp2,MECP2 NP_004983.1,NP_073164.2,NP_034918.1 M y y y
452 MeCP2 M6818
075
siRNA plasmid, pKD-ROKa/ROCK-II-v6 H M R RNAi 5 µg 62-076
ROKa/ROCK-II, active KA 10 µg 14-451
ROKb/ROCK-I, active KA 10 µg 14-601
SHC
SHC is expressed as three alternatively spliced adapter
Applications Format Host Quantity Cat. No.
37
Protein
ROKa/ROCK-II, active KA 10 µg 14-451
ROKb/ROCK-I, active KA 10 µg 14-601
siRNA
siRNA plasmid, pKD-ROKa/ROCK-II-v4 H M R RNAi